Lumrotatug (CM-313)
(Redirected from CM-313)
Mechanism of action
Anti-CD38 monoclonal antibody
Diseases for which it is used
History of changes in NMPA indication
- 2024: Initial approval for immune thrombocytopenia (unclear details). (Based on 2022-CM313-ITP)
Also known as
- Code name: CM-313